Ferric Contrast, a contrast agent company founded by faculty from the University at Buffalo in New York, says doctors and patients want new options in MR imaging.

German scientists found six of seven patients with difficult-to-treat cancer had genetic mutations in their DNA damage-repair genes, according to new research.

Vancouver, British Columbia-based Artms will use the funding to help bolster the supply of locally produced radioisotopes, such as technetium-99m.

The research, which included more than 43,000 women, found that slightly under 2% of individuals tagged with a “probably benign” finding were later diagnosed with cancer.

Inflitration occurs when a a radiotracer is not safely injected into an individual's vein, but the true impact of these adverse events remains unknown to patients and physicians.

Mount Sinai researchers found that those with overall higher chest x-ray scores were 6.2 times more likely to require hospitalization.

The Amsterdam-based company noted that this modality has become a useful tool for providers battling the pandemic, given its portability and easy-to-clean surfaces. 

A novel radiotracer and synaptic imaging revealed "widespread" losses throughout the brain, Yale University researchers reported Wednesday.